Article first published online: 26 JUN 2011
Copyright © 2011 American Association for the Study of Liver Diseases
Volume 54, Issue 2, pages 586–596, August 2011
How to Cite
Bansal, R., Prakash, J., Post, E., Beljaars, L., Schuppan, D. and Poelstra, K. (2011), Novel engineered targeted interferon-gamma blocks hepatic fibrogenesis in mice. Hepatology, 54: 586–596. doi: 10.1002/hep.24395
Potential conflict of interest: Dr. Poelstra owns stock in, is a consultant for, and received grants from Biorion Technology. Dr. Schuppan advises and received grants from Gilead and Pfizer. He also advises Takeda, Sanofi-Adventis, Stromedix, and GlaxoSmithKline.
Supported by VICI grant-in-aid from Netherlands Organization for Scientific Research (NWO) and the Technical foundation (STW).
- Issue published online: 25 JUL 2011
- Article first published online: 26 JUN 2011
- Accepted manuscript online: 29 APR 2011 11:10AM EST
- Manuscript Accepted: 19 APR 2011
- Manuscript Received: 9 FEB 2011
Additional Supporting Information may be found in the online version of this article.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.